Satoh, Mari <br/><br/>
Long-term effects of recombinant human insulin-like growth factor I treatment on glucose and lipid metabolism and the growth of a patient with congenital generalized lipodystrophy.  [electronic resource] 

 -  Endocrine journal  Oct 2006 
 - 639-45 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0918-8959 
<br/><br/><label>Standard No.: </label>10.1507/endocrj.k06-014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Blood Proteins--analysis<br/>Female<br/>Glucose--metabolism<br/>Glucose Tolerance Test<br/>Glycated Hemoglobin--analysis<br/>Growth and Development--drug effects<br/>Humans<br/>Insulin-Like Growth Factor I--adverse effects<br/>Lipid Metabolism--drug effects<br/>Lipodystrophy, Congenital Generalized--drug therapy<br/>Recombinant Proteins--therapeutic use<br/>Time